Skip to main content

Table 2 Core sets of trial outcome measures

From: Outcome measures in inflammatory rheumatic diseases

Rheumatoid arthritis

Psoriatic arthritis

Ankylosing spondylitis

Acute phase reactants

Acute phase reactants

Acute phase reactants

Swollen joint count

Joint counts

Joint counts

Tender joint count

Axial skeleton

Enthesitis

Observer global rating

Observer global rating

Spinal mobility

Patient global rating

Dactylitis

Stiffness

Patient pain rating

Enthesitis

Patient global rating

Physical function

Psoriasis extent

Patient pain rating

Joint damage by X-ray

Nail involvement

Physical function

 

Patient pain rating

 
 

Patient itching rating

 
 

Physical function

 
 

Joint damage by X-ray

 
  1. Trial outcome measures deemed important for disease modifying anti-rheumatic therapies in rheumatoid arthritis [20, 21], psoriatic arthritis [22], and ankylosing spondylitis [23].